


Healthcare | Small Cap
Dr Lal Pathlabs Ltd. demonstrates exceptional financial health, characterized by outstanding profitability and robust growth. The company is highly effective at turning revenue into profit and is expanding its earnings and sales at an impressive rate. Its financial foundation is remarkably strong, with very low reliance on debt, which minimizes financial risk. The company also maintains a very strong capacity to cover its immediate financial obligations. A key area of mixed performance is in its operational efficiency; while it manages its inventory and customer payments very effectively, it is not generating as much sales from its long-term assets as it could be. There is also a potential concern regarding the sustainability of its dividend payments, as earnings do not appear to fully cover them. Overall, the company's strong profitability and growth paint a positive picture, supported by a secure financial structure.
Dr Lal Pathlabs Ltd. demonstrates exceptional financial health, characterized by outstanding profitability and robust growth. The company is highly effective at turning revenue into profit and is expanding its earnings and sales at an impressive rate. Its financial foundation is remarkably strong, with very low reliance on debt, which minimizes financial risk. The company also maintains a very strong capacity to cover its immediate financial obligations. A key area of mixed performance is in its operational efficiency; while it manages its inventory and customer payments very effectively, it is not generating as much sales from its long-term assets as it could be. There is also a potential concern regarding the sustainability of its dividend payments, as earnings do not appear to fully cover them. Overall, the company's strong profitability and growth paint a positive picture, supported by a secure financial structure.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
56.84
Industry Median
30.45
Small Cap Median
30.45
P/E RATIO
57.20
P/B RATIO
11.49
Industry Median
3.55
Small Cap Median
3.55
P/S RATIO
10.48
Industry Median
3.21
Small Cap Median
3.21
Others
PEG RATIO
4.54
EV/EBITDA RATIO
33.07
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹1723.3 as on Jul 15, 2026.
The company is experiencing a period of outstanding growth across all major financial dimensions. Revenues, profits, and earnings per share are all expanding at an excellent rate. This comprehensive growth indicates strong market demand for its services, successful business strategies, and effective management. The expansion of its asset base suggests continued investment to support future growth. This strong upward trajectory is a very positive sign for the company's future prospects and its ability to create value for shareholders.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 32.01 | -3.35 | 10.41 | 10.51 | 12.27 |
| Operating Profit Growth Rate | 28.67 | -12.66 | 24.29 | 14.61 | 12.03 |
| Earnings Per Share (EPS) Growth | 18.3 | -30.74 | 49.48 | 36.04 | 3.4 |
| Asset Growth Rate | 41.06 | 1.71 | 2.98 | 10.55 | 15.96 |
| Net Income Growth Rate | 18.24 | -31.14 | 50.21 | 35.91 | 3.66 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Dr Lal Pathlabs Ltd | 8.79 | 57.20 | Highly Overvalued | 782.00 | 30.32 | 510.00 |
| 2 | Vijaya Diagnostic Centre Ltd | 8.44 | 82.65 | Neutral | 337.00 | 17.33 | 173.00 |
| 3 | Indegene Ltd | 7.58 | 30.69 | Neutral | 619.00 | 8.80 | 401.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Concall Report⬤3rd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Annual Report⬤2nd Jul 26
Annual Report 2025-26
UNDEFINED SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT